Report cover image

Actemra Market, By Indication (Rheumatoid Arthritis, Giant Cell Arteritis (GCA), Polyarticular Juvenile Idiopathic Arthritis (PJIA), Systemic Juvenile Idiopathic Arthritis (SJIA), Cytokine Release Syndrome (CRS), and Systemic Sclerosis-associated Intersti

Published Jun 19, 2025
Length 165 Pages
SKU # CMI20173686

Description

The Global Actemra Market is estimated to be valued at USD 3,023.6 Mn in 2025 and is expected to reach USD 2,373.6 Mn by 2032, declining at a compound annual growth rate (CAGR) of -3.4% from 2025 to 2032.

The global Actemra market has faced a slowdown in recent years, marked by a negative compound annual growth rate (CAGR). While the treatment remains effective in managing autoimmune disorders like rheumatoid arthritis and giant cell arteritis, several challenges have hindered market growth. High treatment costs, potential side effects, and the availability of alternative therapies have limited the demand for Actemra. The entry of biosimilars and the expiration of patents further intensified competition, slowing the market's expansion. These factors combined have contributed to a decline in market growth, resulting in limited prospects for significant expansion in the near term.

Market Dynamics

The market still presents some opportunities for recovery, primarily through the growing focus on personalized medicine and expanding research that could uncover new therapeutic indications for Actemra. Emerging markets remain a potential growth area, but the overall market trajectory is likely to remain subdued, with limited prospects for significant expansion due to pricing pressures and the increasing presence of biosimilars.

Key Features of the Study
  • This report provides in-depth analysis of the global Actemra market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Actemra market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Genentech (Part of Roche)and Chugai Pharmaceutical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Actemra market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Actemra market
Market Segmentation
  • Indication Insights (Revenue, USD Mn, 2020 - 2032)
  • Rheumatoid Arthritis
  • Giant Cell Arteritis (GCA)
  • Polyarticular Juvenile Idiopathic Arthritis (PJIA)
  • Systemic Juvenile Idiopathic Arthritis (SJIA)
  • Cytokine Release Syndrome (CRS)
  • Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
  • Strength Insights (Revenue, USD Mn, 2020 - 2032)
  • 80 mg/4 mL (20 mg/mL)
  • 200 mg/10 mL (20 mg/mL)
  • 400 mg/20 mL (20 mg/mL)
  • 162 mg/0.9 mL for Injection
  • Packaging Insights (Revenue, USD Mn, 2020 - 2032)
  • Single-dose vials
  • Single-dose prefilled syringe or autoinjector
  • Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
  • Subcutaneous
  • Intravenous
  • Age Group Insights (Revenue, USD Mn, 2020 - 2032)
  • Adult
  • Pediatric
  • Geriatric
  • Sales Channel Insights (Revenue, USD Mn, 2020 - 2032)
  • Online
  • Offline
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals
  • Specialized Infusion Centers
  • Others (Academics and Research Institutes, etc.)
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Genentech (Part of Roche)
  • Chugai Pharmaceutical Co., Ltd.

Table of Contents

165 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Actemra Market, By Indication
Global Actemra Market, By Strength
Global Actemra Market, By Packaging
Global Actemra Market, By Route of Administration
Global Actemra Market, By Age Group
Global Actemra Market, By Sales Channel
Global Actemra Market, By End User
Global Actemra Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Industry Trends
Reimbursement Scenario
Epidemiology
Pricing Analysis
4. Global Actemra Market, By Indication, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Rheumatoid Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Giant Cell Arteritis (GCA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Polyarticular Juvenile Idiopathic Arthritis (PJIA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Systemic Juvenile Idiopathic Arthritis (SJIA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cytokine Release Syndrome (CRS)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Actemra Market, By Strength, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
80 mg/4 mL (20 mg/mL)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
200 mg/10 mL (20 mg/mL)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
400 mg/20 mL (20 mg/mL)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
162 mg/0.9 mL for Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Actemra Market, By Packaging, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Single-dose vials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Single-dose prefilled syringe or autoinjector
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Actemra Market, By Route of Administration, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Subcutaneous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Actemra Market, By Age Group, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Actemra Market, By Sales Channel, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Online
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Offline
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global Actemra Market, By End User, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Specialized Infusion Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Academics and Research Institutes, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
11. Global Actemra Market, By Region, 2020 - 2032, Value (USD Mn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
South Africa
North Africa
Central Africa
12. Competitive Landscape
Genentech (Part of Roche)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Chugai Pharmaceutical Co., Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
13. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
14. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on ‘Actemra Market' - Global forecast to 2032
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.